Cell-based vaccines

Efforts are being made to shift from traditional egg-based vaccine production to cell-based methods, which offer faster, more stable production, higher yields, and the potential for multiple vaccines in the same platform. Cell culture technology, using various cell lines including HEK293, offers a more flexible, sterile environment for vaccine production, potentially providing better protection than egg-based vaccines. Recombinant Insulin added to chemically defined media increases viral production in cell-based systems.